Table 3.
Number of | Percent with | ||||||
---|---|---|---|---|---|---|---|
Outcome | Comparator | Trials | Patients | Ferric carboxymaltose |
Control | RB 95% CI |
NNT 95% CI |
Target ferritin increase | All | 3 | 611 | 61 | 43 | 1.6 (1.3 to 1.9) | 5.6 (3.9 to 10) |
Oral iron | 2 | 428 | 59 | 22 | 2.7 (2.0 to 3.6) | 2.7 (2.2 to 3.6) | |
Target TSAT increase | All | 3 | 611 | 65 | 62 | 1.1 (0.9 to 1.2) | not calculated |
Oral iron | 2 | 428 | 64 | 59 | 1.1 (0.9 to 1.3) | not calculated |